Cookies?
Library Header Image
LSE Research Online LSE Library Services

The fate of FTC v. Actavis, Inc. in the biosimilar context - does and should the FTC v. Actavis decision apply to reverse patent settlements between brand drug and biosimilar manufacturers?

Ho, Nicola Gabrielle (2022) The fate of FTC v. Actavis, Inc. in the biosimilar context - does and should the FTC v. Actavis decision apply to reverse patent settlements between brand drug and biosimilar manufacturers? Biotechnology Law Report, 41 (4). 194 - 199. ISSN 0730-031X

Full text not available from this repository.
Identification Number: 10.1089/blr.2022.29274.nho
Item Type: Article
Official URL: https://home.liebertpub.com/publications/biotechno...
Additional Information: © 2022 Mary Ann Liebert, Inc.
Divisions: LSE
Subjects: R Medicine > RA Public aspects of medicine > RA1001 Forensic Medicine. Medical jurisprudence. Legal medicine
Date Deposited: 13 Sep 2022 09:33
Last Modified: 19 Mar 2024 08:18
URI: http://eprints.lse.ac.uk/id/eprint/116601

Actions (login required)

View Item View Item